Synthorx Initiates Patient Dosing in Australia and Announces Clearance of IND in the U.S. for Lead Immuno-oncology Product Candidate, THOR-707

July 24, 2019

We're not around right now. But you can send us an email and we'll get back to you, asap.

Start typing and press Enter to search